- Home
- DYN vs HUN Comparison
DYN vs HUN Comparison
Compare DYN & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | HUN |
|---|---|---|
| Founded | 1984 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DYN | HUN |
|---|---|---|
| Price | $16.60 | $13.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 11 |
| Target Price | ★ $39.94 | $11.00 |
| AVG Volume (30 Days) | 2.1M | ★ 6.0M |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,780,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.32 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.36 | $7.30 |
| 52 Week High | $25.00 | $18.53 |
Technical Indicators
Market Signals| Indicator | DYN | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 67.64 |
| Support Level | $16.10 | $13.04 |
| Resistance Level | $17.45 | $13.96 |
| Average True Range (ATR) | 1.01 | 0.61 |
| MACD | -0.07 | 0.16 |
| Stochastic Oscillator | 15.50 | 92.44 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.